PUBLIC - Croatia, the War, and the Future
PUBLIC - Croatia, the War, and the Future
PUBLIC - Croatia, the War, and the Future
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Equoral solution oral solution<br />
ERAZON capsules 10 mg capsules, hard<br />
ERAZON capsules 20 mg capsules, hard<br />
ERAZON suppositories suppositories<br />
Erbitux 2 mg/mL solution<br />
for infusion<br />
Ergometrin Lek 0.2 mg film<br />
coated tablets<br />
Ergometrin Lek 0.2 mg/mL<br />
solution for injection<br />
Eritromicin 250 mg<br />
capsules<br />
solution for infusion<br />
film coated tablets<br />
solution for injection<br />
capsules<br />
Esberitox N tablets tablets<br />
Esmeron<br />
Esmeron<br />
solution for injection (for<br />
intravenous use)<br />
solution for injection (for<br />
intravenous use)<br />
Espumisan capsules, soft<br />
Estracomb TTS transdermal patch<br />
Estracyt capsules<br />
IVAX-Pharmaceuticals<br />
s.r.o., Ostravska 29,<br />
Opava - Komarov,<br />
Czech Republic<br />
Farmal d.d., Ludbreg,<br />
Republic of <strong>Croatia</strong> in<br />
cooperation with Krka<br />
d.d., Novo mesto,<br />
Republic of Slovenia<br />
Farmal d.d., Ludbreg,<br />
Republic of <strong>Croatia</strong> in<br />
cooperation with Krka<br />
d.d., Novo mesto,<br />
Republic of Slovenia<br />
Farmal d.d., Ludbreg,<br />
Republic of <strong>Croatia</strong> in<br />
cooperation with Krka<br />
d.d., Novo mesto,<br />
Republic of Slovenia<br />
Merck KGaA,<br />
Frankfurter Straße 250,<br />
Darmstadt, Germany<br />
Lek farmacevtska<br />
družba d.d.,<br />
Verovškova 57,<br />
Ljubljana, Republic of<br />
Slovenia<br />
Lek farmacevtska<br />
družba d.d.,<br />
Verovškova 57,<br />
Ljubljana, Republic of<br />
Slovenia<br />
Belupo, lijekovi i<br />
kozmetika d.d., Ulica<br />
Danica 5, Koprivnica,<br />
Republic of <strong>Croatia</strong><br />
Schaper & Brümmer<br />
GmbH & Co. KG,<br />
Salzgitter, Germany<br />
N.V. Organon, Oss,<br />
The Nederl<strong>and</strong>s<br />
N.V. Organon, Oss, <strong>the</strong><br />
Ne<strong>the</strong>rl<strong>and</strong>s;<br />
ORGANON S.A.,<br />
Usine Saint Charles,<br />
France<br />
Berlin-Chemie AG<br />
(Menarini Group),<br />
Glienicker Weg 125,<br />
Berlin, Germany<br />
Novartis Pharma Stein<br />
AG,<br />
Schaffhauserstrasse,<br />
Stein, Switzerl<strong>and</strong><br />
Pliva <strong>Croatia</strong> Ltd.,<br />
Zagreb, Republic of<br />
<strong>Croatia</strong> in cooperation<br />
50 mL of solution in an<br />
amber glass bottle in a<br />
protective container, 1 plastic<br />
syringe of 4 mL, 1 plastic<br />
pipe for extraction of bottle<br />
content in a protective plastic<br />
container <strong>and</strong> 1 plastic<br />
temper-evident screw cap,<br />
supplied in a carton box<br />
20 (2x10) capsules in a<br />
blister (PVC -Al), supplied in<br />
a box<br />
20 (2x10) capsules in a<br />
blister (PVC -Al), supplied in<br />
a box<br />
10 (2x5) suppositories in a<br />
strip, supplied in a box<br />
50 mL of solution in a glass<br />
bottle, supplied in a box<br />
20 film coated tablets in an<br />
amber glass bottle, supplied<br />
in a box<br />
50 ampoules with 1 mL of<br />
solution, supplied in a carton<br />
box<br />
16 (1x16) capsules in a<br />
blister, supplied in a box<br />
50 (5x10) tablets in a blister<br />
(PVC/PVDC/Al), supplied in<br />
a box<br />
10 mL of solution for injection<br />
in a glass bottle with rubber<br />
stopper, 10 glass bottles in a<br />
box<br />
5 mL of solution for injection<br />
in a glass bottle with a rubber<br />
stopper, 12 glass bottles in a<br />
box<br />
25 (1x25) capsules in a<br />
PVC/Al blister, supplied in a<br />
box<br />
4 transdermal patches<br />
Estraderm TTS 50 <strong>and</strong> 4<br />
transdermal patches<br />
Estragest TTS 250/50<br />
(individually packed in a<br />
protective Surlyn/Al bag),<br />
supplied in a box<br />
40 capsules in an amber<br />
glass bottle, supplied in a<br />
box<br />
YES YES<br />
YES YES<br />
YES YES<br />
YES YES<br />
YES YES YES<br />
YES YES<br />
YES YES<br />
YES YES<br />
YES YES<br />
YES YES<br />
YES YES<br />
YES YES YES<br />
YES YES<br />
YES YES<br />
14509/11 WS/jj 278<br />
ANNEX II DGF 2A / DG K 2 EN
Change language